Medical Industry Feature
Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.
46-60 of 117
Aiming to Stay Lower for Longer: Exploring the Clinical Evidence for Long-term LDL-C Reduction
Medical Industry FeatureAiming to Stay Lower for Longer: Exploring the Clinical Evidence for Long-term LDL-C Reduction
Andrew Freeman, MD, FACC, FACP
Lily Dastmalchi, DO
Advancing Care in Chronic GVHD: Evolving Therapeutic Insights
Project Oncology®Advancing Care in Chronic GVHD: Evolving Therapeutic Insights
Brian P. McDonough, MD, FAAFP
Brooke Adams, PharmD, BCOP
Cerebral Organoid Model Transforms Glioblastoma Research
Medical Industry FeatureCerebral Organoid Model Transforms Glioblastoma Research
Howard Fine, M.D.
Clinical Features and Outcomes of IOFB Removal
New Retina RadioClinical Features and Outcomes of IOFB Removal
Socioeconomic Determinants and Outcomes in Proliferative Sickle Retinopathy
Clinical Minute RetinaSocioeconomic Determinants and Outcomes in Proliferative Sickle Retinopathy
María H. Berrocal, MD
Audina Berrocal, MD
Treatment Decisions in mCSPC: A Review of Retrospective Real-World Evidence
Medical Industry FeatureTreatment Decisions in mCSPC: A Review of Retrospective Real-World Evidence
Jennifer Caudle, DO, FACOFP
Gregory McMahon, DO
- advertisement
Potential for Early Intervention in 1L HR+/HER2- Advanced Breast Cancer
Medical Industry FeaturePotential for Early Intervention in 1L HR+/HER2- Advanced Breast Cancer
Seth Wander, MD, PhD
Retinal Perfusion, Sensitivity, and Function in DR
Medical Industry FeatureRetinal Perfusion, Sensitivity, and Function in DR
Barton Lynn Blackorby, MD
Katherine E. Talcott, MD
Hong-Uyen Hua, MD
Ana’s Story – A Real Patient Living With Ulcerative Colitis
Medical Industry FeatureAna’s Story – A Real Patient Living With Ulcerative Colitis
Ana, A Real Patient Living With Ulcerative Colitis
Lukasz Kwapisz, MD
Long-Term Efficacy and Safety Data in Ulcerative Colitis
Medical Industry FeatureLong-Term Efficacy and Safety Data in Ulcerative Colitis
Erica Cohen, MD
Redefining Durability in Wet AMD: Insights from the SOL‑1 Superiority Trial
Medical Industry FeatureRedefining Durability in Wet AMD: Insights from the SOL‑1 Superiority Trial
Priya Vakharia, MD
Andrew Moshfeghi
Under the Radar: Diagnosing Hereditary ATTR Across Specialties
Medical Industry FeatureUnder the Radar: Diagnosing Hereditary ATTR Across Specialties
Charles Turck, PharmD, BCPS, BCCCP
Kevin Alexander, MD
Anasheh Halabi, MD, PhD
- advertisement
Albuminuria: An Overlooked Red Flag in Cardiovascular Risk
Conversations in CV Risk AssessmentAlbuminuria: An Overlooked Red Flag in Cardiovascular Risk
Matthew Sorrentino, MD
Ashish Verma, MBBS
Exploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Medical Industry FeatureExploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Brian P. McDonough, MD, FAAFP
Julie Paik, MD, MHS
Hidden High Risk: When BP Control Isn’t Enough in Hypertension
Conversations in CV Risk AssessmentHidden High Risk: When BP Control Isn’t Enough in Hypertension
Gates B. Colbert, MD
Michael E. Hall, MD
Clyde W. Yancy, MD